HPB Surgery and Liver Transplantation, Division of Surgery and Interventional Science, Royal Free Hospital London, University College London, London, United Kingdom.
Department of Liver Surgery, Birmingham Children's Hospital National Health Service Foundation Trust, Birmingham, United Kingdom.
Liver Transpl. 2018 Dec;24(12):1746-1756. doi: 10.1002/lt.25334.
The cava-preserving piggyback (PB) technique requires only partial cava clamping during the anhepatic phase in liver transplantation (LT) and, therefore, maintains venous return and may hemodynamically stabilize the recipient. Hence, it is an ongoing debate whether PB implantation is more protective from acute kidney injury (AKI) after LT when compared with a classic cava replacement (CR) technique. The aim of this study was to assess the rate of AKI and other complications after LT comparing both transplant techniques without the use of venovenous bypass. We retrospectively analyzed the adult donation after brain death LT cohort between 2008 and 2016 at our center. Liver and kidney function and general outcomes including complications were assessed. Overall 378 transplantations were analyzed, of which 177 (46.8%) were performed as PB and 201 (53.2%) as CR technique. AKI occurred equally often in both groups. Transient renal replacement therapy was required in 22.6% and 22.4% comparing the PB and CR techniques (P = 0.81). Further outcome parameters including the complication rate were similar in both cohorts. Five-year graft and patient survival were comparable between the groups with 81% and 85%, respectively (P = 0.48; P = 0.58). In conclusion, both liver implantation techniques are equal in terms of kidney function and overall complications following LT.
保留腔静脉的劈离式肝移植(PB)技术在肝移植(LT)的无肝期仅需部分夹闭腔静脉,因此可维持静脉回流,并可能使受者血流动力学稳定。因此,目前仍存在争议,即在 LT 后,与经典腔静脉置换(CR)技术相比,PB 植入术是否能更好地预防急性肾损伤(AKI)。本研究旨在评估在不使用静脉-静脉旁路的情况下,比较两种移植技术后 AKI 及其他并发症的发生率。我们回顾性分析了 2008 年至 2016 年在本中心进行的成人脑死亡供肝 LT 队列。评估了肝脏和肾脏功能以及包括并发症在内的一般结果。总共分析了 378 例移植,其中 177 例(46.8%)采用 PB 技术,201 例(53.2%)采用 CR 技术。两组 AKI 的发生率相当。比较 PB 和 CR 技术,分别有 22.6%和 22.4%的患者需要临时肾脏替代治疗(P = 0.81)。两组的其他预后参数(包括并发症发生率)相似。两组的 5 年移植物和患者存活率相当,分别为 81%和 85%(P = 0.48;P = 0.58)。总之,在 LT 后肾功能和总体并发症方面,两种肝植入技术的效果相当。